Risk Assessment Tool for Graft Survival in Pediatric Kidney Transplantation

Registry study in which data of all pediatric kidney recipients in the Netherlands (registered in the Nederlandse Orgaan Transplantatie Registry) are studied to develop a risk calculator for graft loss.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Kidney Transplant Failure and Rejection Behavior Pediatric Kidney Disease Rejection, Psychology Social Behavior

Age range

0 year–18 year

Sex eligibility

All sexes

Study type

Observational

About this study

The pre-transplantation parameters of all recipients are used to do a multivariable regression analysis.

The B-coefficients of this analysis will be used to develop a risk calculator that predicts graft survival after transplantation per year of transplantation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pediatric kidney recipients

transplantation in the Netherlands
signed informed consent

Exclusion criteria

combined transplantation (pancreas-kidney of liver-kidney transplantation)
No informed consent

Treatment and study plan

None, transplantation recipients

Other

None, observational

Primary outcomes

Graft survival

Time frame: Up to 50 years after transplantation

Functioning graft of death with functioning graft. Survival graph: Percentage recipients with a functioning graft over time

Sponsors and collaborators

Lead sponsor

Radboud University Medical Center

Other

Registry information

Official study title

A Pre-transplantation Risk Assessment Tool for Graft Survival After Pediatric Kidney Transplantation Based on 1425 Dutch Transplantations

Important dates

Study start: 1966
Primary completion: 2022
Study completion: 2022
First posted: May 24, 2022
Registry last updated: Dec 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed